Acadia Healthcare (NASDAQ:ACHC) Reaches New 12-Month High Following Earnings Beat

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reached a new 52-week high on Thursday following a stronger than expected earnings report. The company traded as high as $39.38 and last traded at $36.8190, with a volume of 485,555 shares trading hands. The stock had previously closed at $32.25.

The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $895.31 million for the quarter, compared to the consensus estimate of $877.76 million. During the same period last year, the firm posted $0.72 EPS. Acadia Healthcare’s revenue for the quarter was up 5.1% on a year-over-year basis.

Key Headlines Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, ahead of the $0.46 consensus estimate, and revenue of $895.3 million versus expectations of $877.8 million. Revenue increased 5.1% year over year. Read More.
• Positive Sentiment: The company raised its full-year 2026 financial guidance, with its outlook described as slightly above expectations. Same-facility revenue grew 5.2%, supported by a 1.1% increase in patient days and 4.0% growth in revenue per patient day. Read More.
• Negative Sentiment: Despite beating analysts’ estimates, quarterly EPS was down from $0.72 a year earlier, a year-over-year comparison that tempers the otherwise favorable results. Read More.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ACHC. UBS Group increased their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Raymond James Financial cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target for the company. in a research note on Monday, September 28th. KeyCorp boosted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Guggenheim upped their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Finally, Barclays lifted their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $30.69.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Penn Capital Management Company LLC acquired a new stake in Acadia Healthcare in the 3rd quarter valued at about $15,434,000. Prescott Group Capital Management L.L.C. lifted its holdings in shares of Acadia Healthcare by 40.0% in the third quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company’s stock valued at $1,925,000 after purchasing an additional 20,000 shares in the last quarter. Pinnacle Wealth Planning Services Inc. grew its position in shares of Acadia Healthcare by 20.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after purchasing an additional 550 shares during the last quarter. Congress Asset Management Co. increased its stake in shares of Acadia Healthcare by 20.8% during the 3rd quarter. Congress Asset Management Co. now owns 287,390 shares of the company’s stock worth $7,903,000 after purchasing an additional 49,418 shares in the last quarter. Finally, WINTON GROUP Ltd raised its position in shares of Acadia Healthcare by 1.4% during the 2nd quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock worth $7,543,000 after purchasing an additional 3,449 shares during the last quarter.

Acadia Healthcare Price Performance

The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The company has a 50-day moving average of $29.18 and a 200-day moving average of $25.91. The stock has a market capitalization of $3.34 billion, a price-to-earnings ratio of -2.88, a P/E/G ratio of 9.54 and a beta of 0.64.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.